YIDA CHINA (03639) appoints Tang Yongzhi and Chen Yichuan as independent non-executive directors.
Yida China (03639) announced that Mr. Han Gensheng has resigned as an independent non-executive director due to his desire to devote more time to his personal affairs.
YIDA CHINA (03639) announced that Mr. Han Gensheng has resigned as an independent non-executive director due to his desire to dedicate more time to personal matters. He will also no longer serve as a member of the company's audit committee, remuneration committee, and nomination committee, effective from January 13, 2025.
On the same day, Mr. Tang Yongzhi and Mr. Chen Yichuan have been appointed as independent non-executive directors. Mr. Tang Yongzhi has been appointed as a member of the audit committee and remuneration committee, while Mr. Chen Yichuan has been appointed as the chairman of the audit committee and a member of the nomination committee.
Related Articles

ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.

SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.
ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.

SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025